Publications by authors named "Masayuki Endou"

Although GC therapy (the traditional 4-week[4W]regimen)is administered to urothelial cancer patients, discontinuation of gemcitabine after 15 days of administration is a problem. One solution is to use a 3-week (3W) regimen. Because a Japanese study comparing the 3W to the 4W regimens reported the lower efficacy and safety of the 3W regimen, we compared these regimens in a retrospective study.

View Article and Find Full Text PDF
Article Synopsis
  • * Results showed a 59% occurrence of Grade B3 leukopenia and 11% for febrile neutropenia (FN) among participants.
  • * Key factors linked to severe leukopenia included pretreatment white blood cell count, with some support for platelet count, disease extent, and bilirubin level; immediate treatment with G-CSF is recommended for at-risk patients.
View Article and Find Full Text PDF

Background/aims: To evaluate the technical feasibility of the transfemoral approach using a 3.5-Fr catheter system for transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).

Methodology: This study included 81 patients with unresectable HCC who underwent transfemoral TACE using a 3.

View Article and Find Full Text PDF

Unlabelled: The basic mechanisms by which ephedrine is preferred over other vasopressors in obstetric anesthesia have not been clearly defined. We examined the sympathomimetic effects of l-ephedrine, currently used as a vasopressor, and d-pseudoephedrine, currently used as a decongestant. In anesthetized rats, l-ephedrine and d-pseudoephedrine caused dose-dependent increases in arterial blood pressure and heart rate, and these effects disappeared after destruction of the sympathetic nerve terminals with 6-hydroxydopamine (6-OHDA) pretreatment.

View Article and Find Full Text PDF